Leung S, et al., p. 1
Statins and Outcomes in Patients with Bloodstream Infection: A
Propensity-Matched Analysis
1Sharon
Leung, MD, 2Reha Pokharel, MD and 1,3Michelle N. Gong, MD MS
Supplemental Table 1. Bacteria excluded from the study
A.xylosoxidans subsp.xylosoxidans
Actinomyces meyeri
Actinomyces odontolyticus
Aerococcus viridans
Agrobacterium radiobacter
Arcanobacterium haemolyticum
Bacillus species
Bacillus brevis
Bacillus cereus
Bacillus circulans
Bacillus polymyxa
Bifidobacterium species
Brevibacterium casei
Brevibacterium species
Brevundimonas diminuta
All Corynebacterium except Corynebacterium jeikeium
Coryneform group G-2
Coagulase neg Staph except for Staph lugdunensis
Dermabacter hominis
Eubacterium aerofaciens
Eubacterium lentum
Eubacterium limosum
Kluyvera ascorbata
Kocuria varians
Lactococcus lactis
Lactococcus species
Leclercia adecarboxylata
Micrococcus species
Ochrobactrum anthropi(Vd)
Pantoea agglomerans
Porphyromonas gingivalis
Prevotella bivia
Prevotella buccae
Prevotella loescheii
Prevotella melaninogenica
Prevotella oralis
Leung S, et al., p. 2
Propionibacterium granulosum
Propionibacterium acnes
Propionibacterium propionicum
Roseomonas mucosa
Roseomonas species
Shewanella putrefaciens
All Streptococcus except Strep pneumo, beta Strep group and millery group Strep (intermedius,
anginosus and constellatus)
Veillonella species
Leung S, et al., p. 3
Supplemental Table 2. Hazard ratio and 95% CI of different types of statins used
in this study
Variable
HR
95% CI
P value
Simvastatin, n = 451
0.87
0.72 - 1.05
0.143
Atorvastatin, n = 98
0.69
0.43 – 1.09
0.114
Pravastatin, n = 8
1.95
0.62 – 6.18
0.255
Lovastatin, n = 24
0.92
0.51 – 1.66
0.787
Rosuvastatin, n = 11
1.43
0.53 – 3.88
0.472